PATH | VRL
Menu
We've moved! Same resources, new address: vaccineresources.org

Find resources

Total results with these characteristics: 178

Disease: Human papillomavirus (HPV)

Page 5 of 9
Human Papillomavirus Vaccine Delivery Strategies That Achieved High Coverage in Low- and Middle-Income Countries

This article, published in the Bulletin of the World Health Organization, documents human papillomavirus (HPV) vaccination coverage after the demonstration projects conducted in India, Peru, Uganda, and Vietnam by PATH and national governments. …

Author: LaMontagne DS, Barge S, Nga TL, et al.

Publication date: 2011

Human Papillomavirus Vaccines: WHO Position Paper

This article, published in the Weekly Epidemiological Record, is the first World Health Organization (WHO) position paper on vaccines against diseases caused by human papillomaviruses (HPV). It provides essential background information on HPV and …

Author: World Health Organization

Publication date: 2009

Human Papillomavirus Vaccines: WHO Position Paper, May 2017

This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's recommendations on the inclusion of human papillomavirus (HPV) vaccines in national immunization programs. This update replaces their earlier …

Author: World Health Organization

Publication date: 2017

Human Papillomavirus Vaccines: WHO Position Paper, October 2014

This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's recommendations on the inclusion of human papillomavirus (HPV) vaccines in national immunization programs. It focuses primarily on the …

Author: World Health Organization

Publication date: 2014

Human Papillomaviruses: Research Priorities for the Next Decade

This article, published in Trends in Cancer, details human papillomavirus (HPV) infection and the cancers it can cause. It also outlines research priorities going forward, and emphasizes the need for enhanced public health efforts to increase the …

Author: Langsfeld E, Laimins LA

Publication date: 2016

ICO (Institut Català d'Oncologia) Information Centre on HPV and Cancer

This information center was developed to accelerate the development and introduction of prophylactic HPV vaccines in countries with the highest burden of cervical cancer and reduce the incidence of this disease and related lesions among women. It …

Author: Institut Català d’Oncologia

Immunization

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

Author: American Academy of Pediatrics

Immunization Matters

This quarterly e-newsletter provides updates from PATH’s Center for Vaccine Innovation and Access on late-stage and licensed vaccines included in its portfolio as well as its work on health economics and optimization, operations research, and …

Author: PATH

Immunize Canada

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

Author: Immunize Canada

Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam: A Cluster Randomized Noninferiority Trial

A potential barrier to human papillomavirus (HPV) vaccine introduction in low-resource countries is the three-dose schedule over a six-month period of time. This article, published in the Journal of the American Medical Association, describes the …

Author: Neuzil KM, Canh DG, Thiem VD, et al.

Publication date: 2011

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

This article, published in Clinical Infectious Diseases, shares findings of a trial involving 319 human immunodeficiency virus (HIV)-1-infected women in the United States, Brazil, and South Africa. The trial aimed to determine the immunogenicity …

Author: Kojic EM, Kang M, Cespedes MS, et al.

Publication date: 2014

Immunogenicity of Bivalent HPV Vaccine Among Partially Vaccinated Young Adolescent Girls in Uganda

This article, published in Vaccine, reports on a study on the immunogenicity of bivalent human papillomavirus (HPV) vaccine among adolescent girls from Uganda who received one, two, or three vaccine doses. The authors found that even though …

Author: LaMontagne DS, Mugisha E, Pan Y, et al.

Publication date: 2014

Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose

This article, published in the Journal of Infectious Diseases, reports on a study to examine whether immune responses from alternative human papillomavirus (HPV) vaccine schedules are noninferior to the standard schedule two years after …

Author: LaMontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM

Publication date: 2013

The Immunological Basis for Immunization Series

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

Author: World Health Organization

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-World Experience

This article, published in Clinical Infectious Diseases, reports on a study that assessed the global effect of quadrivalent human papillomavirus (HPV) vaccination on HPV infection and disease. The authors found that over the last decade, the impact …

Author: Garland SM, Kjaer SK, Muñoz N, et al.

Publication date: 2016

Implementing HPV Vaccination Programs: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Publication date: 2011

Improved Cervical Cancer Prevention: Planning Now for a Better Future

This report documents an African regional conference on cervical cancer prevention held in September 2010 in Kampala, Uganda. Representatives from nine African countries met to share updates on cervical cancer vaccination and screening programs, and …

Author: PATH, Association of Obstetricians and Gynaecologists of Uganda, Uganda Ministry of Health

Publication date: 2010

Incidence of New-Onset Autoimmune Disease in Girls and Women With Pre-Existing Autoimmune Disease After Quadrivalent Human Papillomavirus Vaccination: A Cohort Study

This article, published in the Journal of Internal Medicine, reports the results of a study to assess whether the quadrivalent human papillomavirus (qHPV) vaccine is associated with increased incidence of autoimmune disease in girls and women with …

Author: Grönlund O, Herweijer E, Sundström K, Arnheim-Dahlström L

Publication date: 2016

Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

This website from the Indian Academy of Pediatrics provides up-to-date information on vaccination for the general public and heath care professionals. It provides a range of resources including information about the latest recommendations by the …

Author: Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

Influences on Parental Acceptance of HPV Vaccination in Demonstration Projects in Uganda and Vietnam

This article, published in Vaccine, reports on a study to investigate the effect of communication strategies on human papillomavirus (HPV) vaccine uptake in HPV vaccine demonstration projects in Uganda and Vietnam. The study found that exposure to …

Author: Galagan SR, Paul P, Menezes L, LaMontagne DS

Publication date: 2013

Page 5 of 9